The given sequence checksum does not match our current record for Q9UKL0!
Q9UKL0 (RCOR1_HUMAN) Homo sapiens (Human)
REST corepressor 1 UniProtKBInterProSTRINGInteractive Modelling
485 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
62 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Human LSD1/CoREST bound to the quinazoline inhibitor MC4106 |
Heteromer O60341; | 1×FAD; 3×NY8; 1×PO4; 5×CL; 1×GOL; 1×DMS; | ||||
| Assess | ||||||
| Human LSD1 Histone Demethylase-CoREST in complex with an FAD- tranylcypromine adduct |
Heteromer O60341; | 1×FAJ; 2×GOL; 1×CL; | ||||
| Assess | ||||||
| LSD1/CoREST1 complex with macrocyclic peptide inhibitor |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Human LSD1/CoREST: LSD1 E379K mutation |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Structural Basis for CoREST-Dependent Demethylation of Nucleosomes by the Human LSD1 Histone Demeth… |
Heteromer O60341; | 1×FAD; 3×CL; 2×GOL; 1×NH4; | ||||
| Assess | ||||||
| Human LSD1/CoREST: LSD1 Y761H mutation |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Structure of the 2a splicing variant of the full-length human LSD1 bound to CoREST (delta305) |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Structural Basis of Histone Demethylation by LSD1 Revealed by Suicide Inactivation |
Heteromer O60341; P68431; | 1×FDA; 1×GOL; 2×CL; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with PRSFAA peptide |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| LSD1(KDM1A)-CoREST in complex with 1-Methyl-Tranylcypromine (1S,2R) |
Heteromer O60341; | 1×D51; | ||||
| Assess | ||||||
| LSD1(KDM1A)-CoREST in complex with 1-Benzyl-Tranylcypromine |
Heteromer O60341; | 1×D69; | ||||
| Assess | ||||||
| LSD1-CoREST1 in complex with quinazoline-derivative reversible inhibitor |
Heteromer O60341; | 1×FAD; 5×E11; 1×NA; | ||||
| Assess | ||||||
| Structure of LSD1:CoREST in complex with ssRNA |
Heteromer O60341; | 4×FAD; 20×SO4; 4×GOL; | ||||
| Assess | ||||||
| LSD1(KDM1A)-CoREST in complex with Z-Pro derivative of MC2580 |
Heteromer O60341; | 1×FAD; 1×M8A; | ||||
| Assess | ||||||
| LSD1/Co-Rest structure with an inhibitor |
Heteromer O60341; | 1×CW0; 1×DTT; 2×ACT; 3×MLA; 4×GOL; 1×D3U; 12×EDO; 3×PEG; 2×CL; | ||||
| Assess | ||||||
| LSD1(KDM1A)-CoREST in complex with 1-Methyl-Tranylcypromine (1R,2S) |
Heteromer O60341; | 1×D73; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with INSM1 peptide |
Heteromer O60341; Q01101; | 1×FAD; | ||||
| Assess | ||||||
| Thieno[3,2-b]pyrrole-5-carboxamides as Novel Reversible Inhibitors of Histone Lysine Demethylase KD… |
Heteromer O60341; | 1×FAD; 1×6W3; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with PLSFLV peptide |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with a N-terminal SNAIL peptide |
Heteromer O60341; O95863; | 1×FAD; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with PRSFAV peptide |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of a neuro-specific splicing variant of human histone lysine demethylase LSD1. |
Heteromer O60341; P68431; | 1×FAD; | ||||
| Assess | ||||||
| LSD1(KDM1A)-CoREST in complex with 1-Ethyl-Tranylcypromine |
Heteromer O60341; | 1×D70; | ||||
| Assess | ||||||
| Structure of the KDM1A/CoREST complex with the inhibitor 4-ethyl-N-[3-(methoxymethyl)-2-[[4-[[(3R)-… |
Heteromer O60341; | 1×FAD; 6×GOL; 1×6X0; | ||||
| Assess | ||||||
| Structure of LSD1-CoREST-Tetrahydrofolate complex |
Heteromer O60341; | 1×FAD; 1×GOL; 1×THG; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with (+)-trans-2- phenylcyclopropyl-1-amine |
Heteromer O60341; | 1×FAD; 1×3PL; | ||||
| Assess | ||||||
| LSD1-CoREST1 in complex with polymyxin E (colistin) |
Heteromer O60341; | 1×FAD; 2×NA; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with PRSFLV peptide |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of a truncated LSD1:CoREST in the presence of an LSD1-NT peptide |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| LSD1(KDM1A)-CoREST in complex with 1-Phenyl-Tranylcypromine |
Heteromer O60341; | 1×D52; | ||||
| Assess | ||||||
| Phosphomimetic mutant of LSD1-8a splicing variant in complex with CoREST |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with para-bromo-(-)-trans- 2-phenylcyclopropyl-1-amine |
Heteromer O60341; | 1×FAD; 1×TCF; | ||||
| Assess | ||||||
| Structural basis of LSD1-CoREST selectivity in histone H3 recognition |
Heteromer O60341; Q16695; | 1×FAD; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with PRLYLV peptide |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Structure of the KDM1A/CoREST complex with the inhibitor 2-[3-{4-chloro-3-[(4-chlorophenyl)ethynyl]… |
Heteromer O60341; | 2×N4K; 1×FAD; 5×GOL; | ||||
| Assess | ||||||
| Thieno[3,2-b]pyrrole-5-carboxamides as Novel Reversible Inhibitors of Histone Lysine Demethylase KD… |
Heteromer O60341; | 1×FAD; 1×6W0; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with a tranylcypromine derivative (MC2580, 14e) |
Heteromer O60341; | 1×FAD; 1×M80; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with a tranylcypromine derivative (MC2584, 13b) |
Heteromer O60341; | 1×FAD; 1×M84; | ||||
| Assess | ||||||
| Thieno[3,2-b]pyrrole-5-carboxamides as Novel Reversible Inhibitors of Histone Lysine Demethylase KD… |
Heteromer O60341; | 1×FAD; 1×6W1; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with PKSFLV peptide |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with para-bromo-(+)-cis-2- phenylcyclopropyl-1-amine |
Heteromer O60341; | 1×FAD; 1×TCF; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with (-)-trans-2- phenylcyclopropyl-1-amine |
Heteromer O60341; | 1×FAD; 1×TCA; | ||||
| Assess | ||||||
| Human LSD1/CoREST: LSD1 D556G mutation |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| LSD1-CoREST1 in complex with quinazoline-derivative reversible inhibitor |
Heteromer O60341; | 1×FAD; 3×767; | ||||
| Assess | ||||||
| Structure of the KDM1A/CoREST complex with the inhibitor 4-methyl-N-[4-[[4-(1-methylpiperidin-4-yl)… |
Heteromer O60341; | 1×FAD; 4×GOL; 2×6X3; | ||||
| Assess | ||||||
| Structure of the KDM1A/CoREST complex with the inhibitor N-[3-(ethoxymethyl)-2-[[4-[[(3R)-pyrrolidi… |
Heteromer O60341; | 1×FAD; 1×6X5; 2×GOL; | ||||
| Assess | ||||||
| LSD1-CoREST1 in complex with polymyxin B |
Heteromer O60341; | 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of the LSD1/CoREST histone demethylase bound to its nucleosome substrate |
Heteromer O60341; P02281; P06897; P62799; P84233; | 2×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with peptide 13 |
Heteromer O60341; P68431; | 1×FAD; 2×GOL; | ||||
| Assess | ||||||
| LSD1-CoREST-S2116 N5 adduct model |
Heteromer O60341; | 5×GOL; 1×DJ0; 1×FAD; | ||||
| Assess | ||||||
| LSD1-CoREST-S2116 five-membered ring adduct model |
Heteromer O60341; | 5×GOL; 1×DJ0; 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRRP peptide |
Heteromer O60341; | 1×FAD; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRKR peptide |
Heteromer O60341; | 1×FAD; 5×GOL; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with peptide 9 |
Heteromer O60341; P68431; | 1×FAD; 3×GOL; | ||||
| Assess | ||||||
| LSD1-CoREST-S2101 five-membered ring adduct model |
Heteromer O60341; | 3×GOL; 1×DJ0; 1×FAD; | ||||
| Assess | ||||||
| LSD1-CoREST-S2101 N5 adduct model |
Heteromer O60341; | 3×GOL; 1×DJ0; 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRR peptide |
Heteromer O60341; | 1×FAD; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of Lysine Specific Demethylase 1 (LSD1) with CC-90011 |
Heteromer O60341; | 1×V0Y; 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with peptide 11 |
Heteromer O60341; P68431; | 4×GOL; 1×FAD; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRRK peptide |
Heteromer O60341; | 1×FAD; 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRRR peptide |
Heteromer O60341; | 1×FAD; 4×GOL; | ||||
| Assess | ||||||
| LSD1-CoREST in complex with 4-[5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile |
Heteromer O60341; | 1×FAD; 1×8WC; 2×GOL; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5l3d.1.B | monomer | 0.55 | 100.00 | |||
| Assess | ||||||